Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             66 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A case of radiation myelopathy after 2 × 8.5 Gy for inoperable non-small cell lung cancer Dardoufas, C.
 1995
 31 13-14 p. 2418-2419
2 p.
 artikel
2 Alpha-fetoprotein-concanavalin a binding as a marker to discriminate between germ cell tumours and liver diseases Mora, J.
 1995
 31 13-14 p. 2239-2242
4 p.
 artikel
3 Anaphylactic reaction after a first filgrastim (GranuLocyte-colony stimulating factor) injection Batel-Copel, L.
 1995
 31 13-14 p. 2428-
1 p.
 artikel
4 A new allogeneic model for metastatic melanoma Robinson, E.S.
 1995
 31 13-14 p. 2302-2308
7 p.
 artikel
5 An I.T.M.O. group study on second-line treatment in advanced epithelial ovarian cancer: an attempt to identify clinical and biological factors determining prognosis Di Leo, A.
 1995
 31 13-14 p. 2248-2254
7 p.
 artikel
6 A phase I/II evaluation of metoclopramide as a radiosensitiser in patients with inoperable squamous cell carcinoma of the lung Kjellén, E.
 1995
 31 13-14 p. 2196-2202
7 p.
 artikel
7 A single-blind, randomised, vehicle-controlled dose-finding study of recombinant human granulocyte colony-stimulating factor (lenograstim) in patients undergoing chemotherapy for solid cancers and lymphoma Seymour, A.-M.
 1995
 31 13-14 p. 2157-2163
7 p.
 artikel
8 Breast cancer in younger women—Journal of the National Cancer Institute Monographs number 16,1994 Castiglione-Gertsch, Monica
 1995
 31 13-14 p. 2412-2413
2 p.
 artikel
9 Calendar of forthcoming meetings 1995
 31 13-14 p. 2429-2433
5 p.
 artikel
10 Can α-tocopherol and β-carotene supplementation reduce adverse radiation effects on salivary glands? Funegård, U.
 1995
 31 13-14 p. 2347-2353
7 p.
 artikel
11 Carboplatin and ifosfamide and selective consolidation in advanced seminoma Amato, R.J.
 1995
 31 13-14 p. 2223-2228
6 p.
 artikel
12 c-erbB-2 expression and benefit from adjuvant chemotherapy and radiotherapy of breast cancer Stål, O.
 1995
 31 13-14 p. 2185-2190
6 p.
 artikel
13 Clinico-pathological features and survival of lung cancer patients in Paris, France Trédaniel, J.
 1995
 31 13-14 p. 2296-2301
6 p.
 artikel
14 Cyclical tumour variations in premenopausal women with early breast cancer Badwe, R.A.
 1995
 31 13-14 p. 2181-2184
4 p.
 artikel
15 Determination of radiation-induced damage in lymphocytes using the micronucleus and microgel electrophoresis ‘Comet’ assays Malcolmson, A.M.
 1995
 31 13-14 p. 2320-2323
4 p.
 artikel
16 Development of immunogenic colorectal cancer cell lines for vaccination: Expression of CD80 (B7.1) is not sufficient to restore impaired primary T cell activation in vitro Habicht, A.
 1995
 31 13-14 p. 2396-2402
7 p.
 artikel
17 Economic analyses of toxicity secondary to anthracycline-based breast cancer chemotherapy Dranitsaris, G.
 1995
 31 13-14 p. 2174-2180
7 p.
 artikel
18 Effects of intrapleural mitoxantrone and mepacrine on malignant pleural effusion—a randomised study Bjermer, L.
 1995
 31 13-14 p. 2203-2208
6 p.
 artikel
19 Efficacy of oral tegafur modulation by uracil and leucovorin in advanced colorectal cancer. A phase II study González-Barón, M.
 1995
 31 13-14 p. 2215-2219
5 p.
 artikel
20 Erratum 1995
 31 13-14 p. 2133-
1 p.
 artikel
21 Ewing's sarcoma of the ribs. A report from the Cooperative Ewing's Sarcoma Study Ozaki, T.
 1995
 31 13-14 p. 2284-2288
5 p.
 artikel
22 Expression of the bacterial nitroreductase enzyme in mammalian cells renders them selectively sensitive to killing by the prodrug CB1954 Bridgewater, J.A.
 1995
 31 13-14 p. 2362-2370
9 p.
 artikel
23 Granulocyte-macrophage colony-stimulating factor therapy in patients with chemotherapy-induced aplasia and Clostridium difficile enterocolitis Geiger, R.
 1995
 31 13-14 p. 2416-2417
2 p.
 artikel
24 High-dose therapy followed by autologous bone marrow transplantation in previously untreated high grade non-Hodgkin's lymphoma: 10-year long-term results Zinzani, P.L.
 1995
 31 13-14 p. 2421-2422
2 p.
 artikel
25 Infrequent occurrence of microsatellite instability in sporadic and familial breast cancer Jönsson, M.
 1995
 31 13-14 p. 2330-2334
5 p.
 artikel
26 Interleukin-2 and interleukin-4 display potent antitumour activity on rat medullary thyroid carcinoma cells Cressent, M.
 1995
 31 13-14 p. 2379-2384
6 p.
 artikel
27 Intermittent hormone therapy in prostate and breast cancers Stoll, B.A.
 1995
 31 13-14 p. 2415-2416
2 p.
 artikel
28 International cancer news 1995
 31 13-14 p. 2129-2133
5 p.
 artikel
29 Key issues in the treatment of chronic lymphocytic leukaemia (CLL) Catovsky, D.
 1995
 31 13-14 p. 2146-2154
9 p.
 artikel
30 Long-term survival in a patient with Rosai-Dorfman disease treated with interferon-α Löhr, H.F.
 1995
 31 13-14 p. 2427-2428
2 p.
 artikel
31 Medullary carcinoma of the breast. Prevalence and prognostic importance of classical risk factors in breast cancer Pedersen, L.
 1995
 31 13-14 p. 2289-2295
7 p.
 artikel
32 Molecular genetic analysis of the von Hippel-Lindau disease (VHl) tumour suppressor gene in gonadal tumours Foster, K.
 1995
 31 13-14 p. 2392-2395
4 p.
 artikel
33 Mutations in the Wilms' tumour gene, WT1. What do they mean? Pritchard-Jones, K.
 1995
 31 13-14 p. 2138-2140
3 p.
 artikel
34 Non-Hodgkin's lymphomas—current status of therapy and future perspectives Hiddemann, W.
 1995
 31 13-14 p. 2141-2145
5 p.
 artikel
35 Oral chemotherapy with doxifluridine and folinic acid in biliary tract cancer Colleoni, M.
 1995
 31 13-14 p. 2426-2427
2 p.
 artikel
36 Phase I and pharmacokinetic study of a water-soluble etoposide prodrug, etoposide phosphate (BMY-40481) Millward, M.J.
 1995
 31 13-14 p. 2409-2411
3 p.
 artikel
37 Phase II study of intensive CEV (Carboplatin, Epirubicin and VP-16) Plus G-CSF (granulocyte-colony stimulating factor) in extensive small cell lung cancer Gridelli, C.
 1995
 31 13-14 p. 2424-2426
3 p.
 artikel
38 p53 Immunoreactive stain and early colorectal adenocarcinomas Hirota, S.
 1995
 31 13-14 p. 2220-2222
3 p.
 artikel
39 Portable pumps in cancer chemotherapy: How to deal with marked fluctuations in 5-Fluorouracil blood concentrations Etienne, M.-C.
 1995
 31 13-14 p. 2414-2415
2 p.
 artikel
40 p53 overexpression as a prognostic factor for advanced stage bladder cancer Kuczyk, M.A.
 1995
 31 13-14 p. 2243-2247
5 p.
 artikel
41 Prognostic factors in chordoma: Role of postoperative radiotherapy Thieblemont, C.
 1995
 31 13-14 p. 2255-2259
5 p.
 artikel
42 Randomised phase II study of epirubicin-vindesine versus mitoxantrone-vindesine in metastatic breast cancer Hausmaninger, H.
 1995
 31 13-14 p. 2169-2173
5 p.
 artikel
43 3rd biannual meeting: “Trends in invasive fungal infection” De Pauw, B.E.
 1995
 31 13-14 p. 2155-2156
2 p.
 artikel
44 Recombinant human granulocyte-macrophage colony-stimulating factor after combined chemotherapy in high-grade non-Hodgkin's lymphoma—a randomised pilot study Bergmann, L.
 1995
 31 13-14 p. 2164-2168
5 p.
 artikel
45 Recombinant human stem cell factor does exert minor stimulation of growth in small cell lung cancer and melanoma cell lines Papadimitriou, C.A.
 1995
 31 13-14 p. 2371-2378
8 p.
 artikel
46 Routine bone scan and serum alkaline phosphatase for staging in patients with renal cell carcinoma is not cost-effective Bos, S.D.
 1995
 31 13-14 p. 2422-2423
2 p.
 artikel
47 Safe selection criteria for breast conservation without radical excision in primary operable invasive breast cancer Sibbering, D.M.
 1995
 31 13-14 p. 2191-2195
5 p.
 artikel
48 Schedule-dependent interaction between paclitaxel and doxorubicin in human cancer cell lines in vitro Akutsu, M.
 1995
 31 13-14 p. 2341-2346
6 p.
 artikel
49 Schedule-dependent therapeutic efficacy of the combination of gemcitabine and cisplatin in head and neck cancer xenografts Braakhuis, B.J.M.
 1995
 31 13-14 p. 2335-2340
6 p.
 artikel
50 Secondary Raynaud's phenomenon and other late vascular complications following chemotherapy for testicular cancer Berger, C.C.
 1995
 31 13-14 p. 2229-2238
10 p.
 artikel
51 Sequential chemoimmunotherapy for advanced non-small cell lung cancer using cisplatin, etoposide, thymosin-αl and interferon-α2a Garaci, E.
 1995
 31 13-14 p. 2403-2405
3 p.
 artikel
52 Short-term versus continuous infusion: No influence on ifosfamide side-chain metabolism Boos, J.
 1995
 31 13-14 p. 2417-2418
2 p.
 artikel
53 Siblings of childhood cancer survivors: How does this “forgotten” group of children adjust after cessation of successful cancer treatment? Van Dongen-Melman, J.E.W.M.
 1995
 31 13-14 p. 2277-2283
7 p.
 artikel
54 Splice variants of the cell surface glycoprotein CD44 associated with metastatic tumour cells are expressed in normal tissues of humans and cynomolgus monkeys Heider, K.-H.
 1995
 31 13-14 p. 2385-2391
7 p.
 artikel
55 Splicing of exon 5 in the WT1 gene is disrupted in Wilms' tumour Simms, L.A.
 1995
 31 13-14 p. 2270-2276
7 p.
 artikel
56 Squamous oesophageal cancer can be downstaged using protracted venous infusion of 5-fluorouracil with epirubicin and cisplatin (ECF) Andreyev, H.J.N.
 1995
 31 13-14 p. 2209-2214
6 p.
 artikel
57 The dithiane Ro 44-5912 enhances vinblastine sensitivity of drug resistant and parental KB lines in vivo Eliason, J.F.
 1995
 31 13-14 p. 2354-2361
8 p.
 artikel
58 The EORTC Core Quality of Life questionnaire (QLQ-C30): validity and reliability when analysed with patients treated with palliative radiotherapy Kaasa, S.
 1995
 31 13-14 p. 2260-2263
4 p.
 artikel
59 The influence of audiotapes on patient participation in the cancer consultation Ford, S.
 1995
 31 13-14 p. 2264-2269
6 p.
 artikel
60 The influence of BIBW22BS, a dipyridamole derivative, on the antiproliferative effects of 5-fluorouracil, methotrexate and gemcitabine in vitro and in human tumour xenografts Jansen, W.J.M.
 1995
 31 13-14 p. 2313-2319
7 p.
 artikel
61 The influence of the local environment on tissue architecture of colorectal carcinoma (CRC) cell aggregates and its consequence for tumour attack by lymphocytes in vitro and in vivo Kammerer, R.
 1995
 31 13-14 p. 2324-2329
6 p.
 artikel
62 Thyroid cancer: Different outcomes to chemotherapy according to tumour histology Biganzoli, L.
 1995
 31 13-14 p. 2423-2424
2 p.
 artikel
63 Towards a cure in indolent lymphoproliferative diseases? Coiffier, B.
 1995
 31 13-14 p. 2135-2137
3 p.
 artikel
64 Trofosfamide is effective in refractory non-Hodgkin's lymphoma Salminen, E.
 1995
 31 13-14 p. 2419-2420
2 p.
 artikel
65 Tumour purine nucleotides and cell proliferation in response to exercise in rats Daneryd, P.
 1995
 31 13-14 p. 2309-2312
4 p.
 artikel
66 Vinorelbine and epirubicin in metastatic breast cancer. A dose finding study Blomqvist, C.
 1995
 31 13-14 p. 2406-2408
3 p.
 artikel
                             66 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland